Women in Pharma: Redefining Careers in Pharma at CPHI Milan 2026
There is a persistent myth in professional life that success follows a straight line — a tidy progression from graduate role to senior leadership, each step logically following the last. For many women in the pharmaceutical industry, the reality looks rather different, and it is this reality that forms the heart of our latest podcast episode.
Hosted by Isabel Kennedy, Business Development Director at Vector, this episode brings together four remarkable women whose careers have taken anything but a predictable path. Maja Pedersen, President & COO at FUJIFILM Biotechnologies, Jenny Gattari, Global Business Development Lead at Pfizer CentreOne, Lorna Murtagh, Portfolio Lead at Pfizer CentreOne, and Henny Zijlstra, Chief Commercial Officer at Ardena, each share candid accounts of the pivots, setbacks, and unexpected opportunities that shaped the leaders they have become.
What makes this conversation so compelling is its honesty. Rather than presenting polished, retrospective narratives where every career move seems inevitable in hindsight, these women discuss the genuine uncertainty that often accompanied their decisions. There are stories of lateral moves that seemed risky at the time, periods of self-doubt, and moments where opportunity arrived from an entirely unexpected direction. For listeners who have ever felt that their own career does not fit a conventional mould, this episode offers reassurance — and proof that there is no single formula for reaching senior leadership in pharma.
The discussion also sheds light on an industry that is itself in constant flux. Pharmaceutical manufacturing, biotechnology, and contract development organisations are evolving rapidly, shaped by scientific innovation, shifting regulatory landscapes, and changing commercial models. Within this context, career paths are becoming less linear by necessity, not just by choice. The guests reflect on how adaptability, curiosity, and a willingness to step outside one's comfort zone have proven more valuable than following any predetermined career blueprint.
Isabel Kennedy guides the conversation with warmth and insight, drawing out practical lessons alongside the personal anecdotes. Listeners can expect discussions around building confidence during periods of transition, the importance of mentorship and sponsorship, and how to make the most of opportunities that may not initially seem connected to one's long-term goals. The panel also touches on the particular challenges women have historically faced in pharma leadership, and how the industry is gradually — if not yet fully — becoming more inclusive.
Beyond the personal stories, this episode serves as a valuable resource for anyone navigating their own career uncertainties, regardless of industry or seniority. The advice shared is practical, grounded, and refreshingly free of corporate platitudes.
Whether you are early in your career and wondering how to plan your next move, or a seasoned professional feeling boxed in by a conventional career trajectory, this episode offers both comfort and inspiration. It is a timely reminder that the most interesting careers are rarely the ones that go exactly to plan.
Tune in to hear these four accomplished women share the twists and turns that led them to where they are today — and discover why embracing a non-linear path might just be the smartest career move you make.
Related News
-
News CPHI Milan 2026: From the Floor
Welcome to our live coverage from the heart of the pharmaceutical industry's most anticipated event of the year! As CPHI Milan 2026 unfolds across the sprawling exhibition halls of Fiera Milano, we're bringing you real-time insights, breakthrou... -
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t...